Clovis Oncology (NASDAQ:CLVS) Expected to Announce Quarterly Sales of $37.26 Million
Analysts forecast that Clovis Oncology (NASDAQ:CLVS – Get Rating) will announce sales of $37.26 million for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Clovis Oncology’s earnings, with the highest sales estimate coming in at $39.43 million and the lowest estimate coming in at $35.08 million. Clovis Oncology posted sales of […]